Trade Proto Labs, Inc. Common stock - PRLB CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.21 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Proto Labs Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 31.08 |
Open* | 30.92 |
1-Year Change* | 2.15% |
Day's Range* | 30.92 - 31.37 |
52 wk Range | 23.01-40.47 |
Average Volume (10 days) | 122.62K |
Average Volume (3 months) | 4.29M |
Market Cap | 924.68M |
P/E Ratio | -100.00K |
Shares Outstanding | 25.79M |
Revenue | 494.44M |
EPS | -3.80 |
Dividend (Yield %) | N/A |
Beta | 1.35 |
Next Earnings Date | Feb 9, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 18, 2024 | 30.97 | 0.05 | 0.16% | 30.92 | 31.44 | 30.86 |
Apr 17, 2024 | 31.08 | -0.07 | -0.22% | 31.15 | 31.49 | 30.94 |
Apr 16, 2024 | 31.22 | -0.10 | -0.32% | 31.32 | 31.60 | 30.81 |
Apr 15, 2024 | 31.73 | 0.01 | 0.03% | 31.72 | 32.27 | 31.42 |
Apr 12, 2024 | 32.16 | -0.11 | -0.34% | 32.27 | 32.47 | 31.90 |
Apr 11, 2024 | 32.72 | 0.03 | 0.09% | 32.69 | 33.12 | 32.41 |
Apr 10, 2024 | 32.80 | -0.28 | -0.85% | 33.08 | 33.16 | 32.28 |
Apr 9, 2024 | 34.18 | 0.94 | 2.83% | 33.24 | 34.27 | 33.24 |
Apr 8, 2024 | 33.84 | 0.07 | 0.21% | 33.77 | 34.45 | 32.49 |
Apr 5, 2024 | 34.04 | 0.61 | 1.82% | 33.43 | 34.48 | 33.43 |
Apr 4, 2024 | 33.86 | -0.21 | -0.62% | 34.07 | 34.95 | 33.79 |
Apr 3, 2024 | 34.42 | 0.81 | 2.41% | 33.61 | 34.66 | 33.09 |
Apr 2, 2024 | 34.25 | 0.07 | 0.20% | 34.18 | 34.27 | 32.76 |
Apr 1, 2024 | 34.71 | -0.82 | -2.31% | 35.53 | 35.53 | 34.58 |
Mar 28, 2024 | 35.63 | 0.39 | 1.11% | 35.24 | 35.95 | 34.90 |
Mar 27, 2024 | 35.28 | 1.03 | 3.01% | 34.25 | 35.30 | 33.90 |
Mar 26, 2024 | 34.20 | -0.17 | -0.49% | 34.37 | 34.85 | 34.14 |
Mar 25, 2024 | 34.41 | -0.23 | -0.66% | 34.64 | 34.76 | 33.87 |
Mar 22, 2024 | 34.67 | -0.15 | -0.43% | 34.82 | 35.38 | 34.54 |
Mar 21, 2024 | 34.94 | 0.76 | 2.22% | 34.18 | 35.06 | 34.05 |
Proto Labs, Inc. Common stock Events
Time (UTC) | Country | Event |
---|---|---|
Friday, May 3, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q1 2024 Proto Labs Inc Earnings Release Q1 2024 Proto Labs Inc Earnings ReleaseForecast -Previous - |
Thursday, May 16, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Proto Labs Inc Annual Shareholders Meeting Proto Labs Inc Annual Shareholders MeetingForecast -Previous - |
Friday, August 2, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q2 2024 Proto Labs Inc Earnings Release Q2 2024 Proto Labs Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 488.398 | 488.098 | 434.395 | 458.728 | 445.596 |
Revenue | 488.398 | 488.098 | 434.395 | 458.728 | 445.596 |
Cost of Revenue, Total | 272.933 | 265.407 | 216.568 | 223.438 | 206.917 |
Gross Profit | 215.465 | 222.691 | 217.827 | 235.29 | 238.679 |
Total Operating Expense | 586.381 | 447.756 | 374.559 | 378.872 | 356.698 |
Selling/General/Admin. Expenses, Total | 150.296 | 138.108 | 121.051 | 122.742 | 121.046 |
Research & Development | 38.222 | 44.241 | 36.94 | 32.692 | 28.735 |
Operating Income | -97.983 | 40.342 | 59.836 | 79.856 | 88.898 |
Other, Net | 0.106 | -0.158 | 3.109 | 1.337 | 2.757 |
Net Income Before Taxes | -97.877 | 40.184 | 62.945 | 81.193 | 91.655 |
Net Income After Taxes | -103.462 | 33.372 | 50.867 | 63.655 | 76.788 |
Net Income Before Extra. Items | -103.462 | 33.372 | 50.867 | 63.655 | 76.788 |
Net Income | -103.462 | 33.372 | 50.867 | 63.655 | 76.588 |
Income Available to Common Excl. Extra. Items | -103.462 | 33.372 | 50.867 | 63.655 | 76.788 |
Income Available to Common Incl. Extra. Items | -103.462 | 33.372 | 50.867 | 63.655 | 76.588 |
Diluted Net Income | -103.462 | 33.372 | 50.867 | 63.655 | 76.588 |
Diluted Weighted Average Shares | 27.4098 | 27.6531 | 26.8964 | 27.0494 | 27.2788 |
Diluted EPS Excluding Extraordinary Items | -3.77463 | 1.20681 | 1.89122 | 2.35328 | 2.81493 |
Diluted Normalized EPS | -0.81203 | 1.20681 | 1.89122 | 2.35328 | 2.81493 |
Total Extraordinary Items | -0.2 | ||||
Unusual Expense (Income) | 124.93 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 122.265 | 125.859 | 115.607 | 121.721 | 126.902 |
Revenue | 122.265 | 125.859 | 115.607 | 121.721 | 126.902 |
Cost of Revenue, Total | 69.142 | 72.083 | 67 | 68.089 | 69.48 |
Gross Profit | 53.123 | 53.776 | 48.607 | 53.632 | 57.422 |
Total Operating Expense | 116.657 | 122.11 | 232.739 | 115.663 | 121.701 |
Selling/General/Admin. Expenses, Total | 37.552 | 39.284 | 38.291 | 37.071 | 37.577 |
Research & Development | 9.865 | 10.677 | 8.906 | 9.309 | 9.45 |
Operating Income | 5.608 | 3.749 | -117.132 | 6.058 | 5.201 |
Other, Net | 0.429 | -0.024 | 0.001 | ||
Net Income Before Taxes | 2.24 | 5.039 | -116.703 | 6.034 | 5.202 |
Net Income After Taxes | -0.383 | 2.659 | -115.065 | 3.951 | 2.557 |
Net Income Before Extra. Items | -0.383 | 2.659 | -115.065 | 3.951 | 2.557 |
Net Income | -0.383 | 2.659 | -115.065 | 3.951 | 2.557 |
Income Available to Common Excl. Extra. Items | -0.383 | 2.659 | -115.065 | 3.951 | 2.557 |
Income Available to Common Incl. Extra. Items | -0.383 | 2.659 | -115.065 | 3.951 | 2.557 |
Diluted Net Income | -0.383 | 2.659 | -115.065 | 3.951 | 2.557 |
Diluted Weighted Average Shares | 26.2105 | 26.6058 | 27.4618 | 27.5082 | 27.5368 |
Diluted EPS Excluding Extraordinary Items | -0.01461 | 0.09994 | -4.19 | 0.14363 | 0.09286 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.01218 | 0.10125 | -1.3842 | 0.20062 | 0.20699 |
Unusual Expense (Income) | 0.098 | 0.066 | 118.542 | 1.194 | 5.194 |
Interest Income (Expense), Net Non-Operating | -3.368 | 1.29 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 186.568 | 183.492 | 242.002 | 236.419 | 215.362 |
Cash and Short Term Investments | 80.126 | 77.509 | 161.691 | 160.662 | 131.796 |
Cash & Equivalents | 56.558 | 65.929 | 127.603 | 125.225 | 85.046 |
Short Term Investments | 23.568 | 11.58 | 34.088 | 35.437 | 46.75 |
Total Receivables, Net | 80.267 | 81.372 | 58.417 | 57.45 | 64.912 |
Accounts Receivable - Trade, Net | 76.225 | 80.051 | 57.877 | 57.45 | 59.155 |
Total Inventory | 13.578 | 13.161 | 10.862 | 10.075 | 10.087 |
Prepaid Expenses | 12.597 | 11.45 | 11.032 | 8.232 | 8.567 |
Total Assets | 802.168 | 928.582 | 744.204 | 673.667 | 618.985 |
Property/Plant/Equipment, Total - Net | 279.161 | 287.822 | 294.917 | 275.137 | 228.001 |
Property/Plant/Equipment, Total - Gross | 479.199 | 469.377 | 445.673 | 396.927 | 323.733 |
Accumulated Depreciation, Total | -200.038 | -181.555 | -150.756 | -121.79 | -95.732 |
Goodwill, Net | 273.991 | 400.61 | 128.752 | 128.752 | 128.752 |
Intangibles, Net | 31.25 | 37.998 | 14.35 | 17.369 | 19.85 |
Long Term Investments | 26.419 | 14.34 | 59.357 | 12.96 | 23.579 |
Other Long Term Assets, Total | 4.779 | 4.32 | 4.826 | 3.03 | 3.441 |
Total Current Liabilities | 71.581 | 54.896 | 50.254 | 47.581 | 52.734 |
Accounts Payable | 17.356 | 25.364 | 18.248 | 16.804 | 17.411 |
Accrued Expenses | 36.688 | 28.982 | 31.454 | 29.455 | 34.832 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 104.52 | 100.089 | 99.848 | 87.877 | 77.488 |
Total Long Term Debt | 0 | 1.351 | 1.919 | 0 | 0 |
Deferred Income Tax | 26.322 | 35.892 | 33.854 | 26.283 | 20.162 |
Other Liabilities, Total | 6.617 | 7.95 | 13.821 | 14.013 | 4.592 |
Total Equity | 697.648 | 828.493 | 644.356 | 585.79 | 541.497 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.027 | 0.028 | 0.027 | 0.027 | 0.027 |
Additional Paid-In Capital | 473.74 | 468.548 | 284.848 | 268.059 | 258.502 |
Retained Earnings (Accumulated Deficit) | 258.236 | 376.734 | 362.901 | 324.722 | 291.46 |
Other Equity, Total | -33.095 | -16.698 | -3.42 | -7.018 | -8.492 |
Total Liabilities & Shareholders’ Equity | 802.168 | 928.582 | 744.204 | 673.667 | 618.985 |
Total Common Shares Outstanding | 26.8884 | 27.466 | 26.7768 | 26.7865 | 26.9848 |
Other Current Liabilities, Total | 0 | 1.322 | 0.491 | ||
Current Port. of LT Debt/Capital Leases | 17.537 | 0.55 | 0.552 | ||
Capital Lease Obligations | 0 | 1.351 | 1.919 | ||
Unrealized Gain (Loss) | -1.26 | -0.119 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 204.511 | 185.152 | 188.716 | 186.568 | 192.357 |
Cash and Short Term Investments | 102.7 | 86.438 | 84.902 | 80.126 | 84.614 |
Cash & Equivalents | 83.496 | 66.493 | 62.051 | 56.558 | 59.361 |
Short Term Investments | 19.204 | 19.945 | 22.851 | 23.568 | 25.253 |
Total Receivables, Net | 79.286 | 75.902 | 78.44 | 80.267 | 81.374 |
Accounts Receivable - Trade, Net | 78.395 | 75.034 | 77.619 | 76.225 | 80.611 |
Total Inventory | 13.803 | 14.311 | 14.273 | 13.578 | 14.617 |
Prepaid Expenses | 8.722 | 8.501 | 11.101 | 12.597 | 11.752 |
Total Assets | 784.245 | 777.21 | 791.373 | 802.168 | 906.938 |
Property/Plant/Equipment, Total - Net | 262.522 | 268.632 | 274.197 | 279.161 | 265.673 |
Goodwill, Net | 273.991 | 273.991 | 273.991 | 273.991 | 383.558 |
Intangibles, Net | 26.668 | 28.353 | 29.869 | 31.25 | 31.907 |
Long Term Investments | 12.212 | 16.344 | 19.824 | 26.419 | 29.257 |
Other Long Term Assets, Total | 4.341 | 4.738 | 4.776 | 4.779 | 4.186 |
Total Current Liabilities | 74.628 | 66.221 | 78.38 | 71.581 | 60.72 |
Accounts Payable | 17.922 | 16.474 | 19.854 | 17.356 | 16.893 |
Accrued Expenses | 38.932 | 32.85 | 39.146 | 36.688 | 42.338 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 16.63 | 16.549 | 17.452 | 17.537 | 1.484 |
Other Current Liabilities, Total | 1.144 | 0.348 | 1.928 | 0.005 | |
Total Liabilities | 99.323 | 94.525 | 108.236 | 104.52 | 96.092 |
Total Long Term Debt | 0.671 | 0.745 | 0 | 0 | 0 |
Capital Lease Obligations | 0.671 | 0.745 | 0 | 0 | |
Deferred Income Tax | 17.138 | 20.79 | 23.258 | 26.322 | 26.864 |
Other Liabilities, Total | 6.886 | 6.769 | 6.598 | 6.617 | 8.508 |
Total Equity | 684.922 | 682.685 | 683.137 | 697.648 | 810.846 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.026 | 0.026 | 0.026 | 0.027 | 0.028 |
Additional Paid-In Capital | 463.908 | 464.95 | 465.185 | 473.74 | 477.107 |
Retained Earnings (Accumulated Deficit) | 251.276 | 246.93 | 251.42 | 258.236 | 380.735 |
Unrealized Gain (Loss) | 0.593 | 0.353 | 0.334 | -1.26 | -0.588 |
Other Equity, Total | -30.881 | -29.574 | -33.828 | -33.095 | -46.436 |
Total Liabilities & Shareholders’ Equity | 784.245 | 777.21 | 791.373 | 802.168 | 906.938 |
Total Common Shares Outstanding | 25.7859 | 26.0954 | 26.2027 | 26.8884 | 27.3267 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -103.462 | 33.372 | 50.867 | 63.655 | 76.588 |
Cash From Operating Activities | 62.079 | 55.242 | 106.969 | 116.052 | 122.929 |
Cash From Operating Activities | 39.425 | 40.488 | 32.594 | 30.864 | 26.754 |
Deferred Taxes | -9.499 | 0.339 | 7.577 | 6.106 | 11.936 |
Non-Cash Items | 137.219 | 19.937 | 14.752 | 11.177 | 10.012 |
Cash Taxes Paid | 19.16 | 7.583 | 5.65 | 4.002 | 9.966 |
Cash Interest Paid | 0.101 | 0.028 | 0.023 | 0.014 | 0.039 |
Changes in Working Capital | -1.604 | -38.894 | 1.179 | 4.25 | -2.361 |
Cash From Investing Activities | -43.092 | -94.664 | -95.473 | -44.303 | -63.281 |
Capital Expenditures | -21.686 | -34.209 | -47.01 | -62.23 | -87.104 |
Other Investing Cash Flow Items, Total | -21.406 | -60.455 | -48.463 | 17.927 | 23.823 |
Cash From Financing Activities | -27.922 | -22.198 | -10.726 | -31.617 | -10.438 |
Financing Cash Flow Items | -1.682 | -4.229 | -3.443 | -2.487 | |
Issuance (Retirement) of Stock, Net | -25.709 | -17.417 | -7.129 | -29.13 | -5.438 |
Issuance (Retirement) of Debt, Net | -0.531 | -0.552 | -0.154 | 0 | -5 |
Foreign Exchange Effects | -0.436 | -0.054 | 1.608 | 0.047 | -0.871 |
Net Change in Cash | -9.371 | -61.674 | 2.378 | 40.179 | 48.339 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2.659 | -103.462 | 11.603 | 7.652 | 5.095 |
Cash From Operating Activities | 22.578 | 62.079 | 51.564 | 31.04 | 17.783 |
Cash From Operating Activities | 9.388 | 39.425 | 29.981 | 20.274 | 10.232 |
Deferred Taxes | -3.096 | -9.499 | -8.92 | -5.653 | -3.213 |
Non-Cash Items | 3.936 | 137.219 | 15.014 | 10.252 | 4.476 |
Changes in Working Capital | 9.691 | -1.604 | 3.886 | -1.485 | 1.193 |
Cash From Investing Activities | 4.383 | -43.092 | -43.365 | -36.516 | -25.835 |
Capital Expenditures | -3.441 | -21.686 | -16.414 | -6.03 | -3.069 |
Other Investing Cash Flow Items, Total | 7.824 | -21.406 | -26.951 | -30.486 | -22.766 |
Cash From Financing Activities | -21.602 | -27.922 | -12.795 | -4.821 | -0.601 |
Financing Cash Flow Items | -0.401 | -1.682 | -1.615 | -1.615 | -0.468 |
Issuance (Retirement) of Stock, Net | -21.119 | -25.709 | -10.763 | -2.928 | 0.006 |
Issuance (Retirement) of Debt, Net | -0.082 | -0.531 | -0.417 | -0.278 | -0.139 |
Foreign Exchange Effects | 0.134 | -0.436 | -1.972 | -0.966 | -0.037 |
Net Change in Cash | 5.493 | -9.371 | -6.568 | -11.263 | -8.69 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Proto Labs, Inc. Common stock Company profile
About Proto Labs Inc
Proto Labs, Inc. is a digital manufacturer of custom prototypes and on-demand production parts. The Company's segments include United States, Europe and Japan. Its primary manufacturing product lines include injection molding, computer numerical control (CNC) machining, three dimensional (3D) printing and sheet metal. It targets its products to product developers and engineers who use 3D computer aided design (3D CAD) software to design products across a range of end-markets. The Company's injection molding product line uses its 3D CAD-to-CNC machining technology for the automated design and manufacture of molds. Its CNC machining product line uses CNC machines to manufacture custom metal and plastic arts. Its 3D printing product line includes a range of technologies in plastics and metals, stereolithography and selective laser sintering, among others. Its sheet metal product line includes quick-turn and e-commerce-enabled custom sheet metal parts and assemblies.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Proto Labs Inc revenues increased 12% to $488.1M. Net income decreased 34% to $33.4M. Revenues reflect United states segment increase of 11% to $384.5M, Europe segment increase of 21% to $90.4M. Net income was offset by Europe segment income decrease of 94% to $730K, Corporate segment loss increase of 15% to $58.4M, United states segment income decrease of 1% to $98M.
Equity composition
Common Stock $.001 Par, 02/12, 150M auth., 23,187,708 issd. Insiders own aprrox.77.4%.
Industry: | Industrial Machinery & Equipment (NEC) |
5540 Pioneer Creek
MAPLE PLAIN
MINNESOTA 55359
US
Income Statement
- Annual
- Quarterly
News
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com